» Articles » PMID: 27755541

Core Outcome Set-STAndards for Reporting: The COS-STAR Statement

Overview
Journal PLoS Med
Specialty General Medicine
Date 2016 Oct 19
PMID 27755541
Citations 246
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Core outcome sets (COS) can enhance the relevance of research by ensuring that outcomes of importance to health service users and other people making choices about health care in a particular topic area are measured routinely. Over 200 COS to date have been developed, but the clarity of these reports is suboptimal. COS studies will not achieve their goal if reports of COS are not complete and transparent.

Methods And Findings: In recognition of these issues, an international group that included experienced COS developers, methodologists, journal editors, potential users of COS (clinical trialists, systematic reviewers, and clinical guideline developers), and patient representatives developed the Core Outcome Set-STAndards for Reporting (COS-STAR) Statement as a reporting guideline for COS studies. The developmental process consisted of an initial reporting item generation stage and a two-round Delphi survey involving nearly 200 participants representing key stakeholder groups, followed by a consensus meeting. The COS-STAR Statement consists of a checklist of 18 items considered essential for transparent and complete reporting in all COS studies. The checklist items focus on the introduction, methods, results, and discussion section of a manuscript describing the development of a particular COS. A limitation of the COS-STAR Statement is that it was developed without representative views of low- and middle-income countries. COS have equal relevance to studies conducted in these areas, and, subsequently, this guideline may need to evolve over time to encompass any additional challenges from developing COS in these areas.

Conclusions: With many ongoing COS studies underway, the COS-STAR Statement should be a helpful resource to improve the reporting of COS studies for the benefit of all COS users.

Citing Articles

The case for development of a core outcome set (COS) and supplemental reporting guidelines for influenza vaccine challenge trial research in swine.

Keay S, Alberts F, OConnor A, Friendship R, OSullivan T, Poljak Z Front Vet Sci. 2025; 12:1465926.

PMID: 40007748 PMC: 11851948. DOI: 10.3389/fvets.2025.1465926.


Development of a core outcome set for paediatric achalasia: a joint ERNICA, ESPGHAN and EUPSA study protocol.

Neville J, den Uijl I, Irvine W, Eaton S, Gottrand F, Hall N BMJ Paediatr Open. 2025; 9(1).

PMID: 39947877 PMC: 11831267. DOI: 10.1136/bmjpo-2024-003130.


Core Outcome Set Development for Tension-Type Headache Treatment Using Traditional Chinese Medicine: Protocol for a Delphi Consensus Study.

Fu G, Chen Y, Liang X, Guo C, Fan X, Gong X JMIR Res Protoc. 2025; 14:e63481.

PMID: 39909408 PMC: 11840383. DOI: 10.2196/63481.


Developing a core outcome set for assessing interventions and care for parents after neonatal death in high-income countries (iCHOOSE Neonatal study): protocol for a mixed-methods study.

Davies A, Williams C, Burden C, Mullin S, Moy L, Redshaw M BMJ Open. 2025; 15(2):e088251.

PMID: 39900413 PMC: 11795395. DOI: 10.1136/bmjopen-2024-088251.


A core outcome set for maternal and neonatal health research and surveillance of emerging and ongoing epidemic threats (MNH-EPI-COS): a modified Delphi-based international consensus.

Pingray V, Klein K, Alonso J, Belizan M, Babinska M, Alger J EClinicalMedicine. 2025; 80:103025.

PMID: 39896875 PMC: 11786750. DOI: 10.1016/j.eclinm.2024.103025.


References
1.
Schmitt J, Apfelbacher C, Spuls P, Thomas K, Simpson E, Furue M . The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Invest Dermatol. 2014; 135(1):24-30. DOI: 10.1038/jid.2014.320. View

2.
Williamson P, Altman D, Blazeby J, Clarke M, Devane D, Gargon E . Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132. PMC: 3472231. DOI: 10.1186/1745-6215-13-132. View

3.
Smith M, Leeder S, Jalaludin B, Smith W . The asthma health outcome indicators study. Aust N Z J Public Health. 1996; 20(1):69-75. DOI: 10.1111/j.1467-842x.1996.tb01340.x. View

4.
Sinha I, Smyth R, Williamson P . Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011; 8(1):e1000393. PMC: 3026691. DOI: 10.1371/journal.pmed.1000393. View

5.
Gargon E, Gurung B, Medley N, Altman D, Blazeby J, Clarke M . Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One. 2014; 9(6):e99111. PMC: 4059640. DOI: 10.1371/journal.pone.0099111. View